Bruker Corporation's stock experienced a significant pre-market plunge of 6.69% on Thursday, following the release of its fourth-quarter financial results.

The sharp decline came after the medical equipment maker reported adjusted earnings per share of $0.59 for the quarter, missing the analyst consensus estimate of $0.65. This represents a 9.09% earnings miss and a 22.37% decrease compared to earnings of $0.76 per share from the same period last year.

While the company's quarterly sales of $977.2 million surpassed analyst expectations of $960.8 million, the substantial profit shortfall appears to have driven investor sentiment negatively in early trading.